NVR RIC (Kisqali 200 mg)
Generic Name: ribociclib
Pill with imprint NVR RIC is Purple, Round and has been identified as Kisqali 200 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Kisqali is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug class CDK 4/6 inhibitors. Kisqali 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR RIC
Kisqali
- Generic Name:
- ribociclib
- Imprint:
- NVR RIC
- Strength:
- 200 mg
- Color:
- Purple
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- CDK 4/6 inhibitors
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC):
- 00078-0874
More about Kisqali (ribociclib)
- Kisqali Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 2 Reviews – Add your own review/rating
- Drug class: CDK 4/6 inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
